TRCT
NBTX

Tower Research Capital (TRC)’s Nanobiotix NBTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio NBTX Stock Details NBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31 Buy
+1
New +$26 ﹤0.01% 5049
2025
Q1 		– Sell
-7,921
Closed -$22.7K – 5586
2024
Q4 		$22.7K Buy
+7,921
New +$31.7K ﹤0.01% 3089
2024
Q2 		– Sell
-450
Closed -$2.92K – 5898
2024
Q1 		$2.92K Buy
+450
New +$3.18K ﹤0.01% 4963

Other funds holding NBTX

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Tower Research Capital (TRC)'s NBTX Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in Nanobiotix (NBTX) in Q1 2026: 1 share worth $31. The stake represents ﹤0.01% of the portfolio and ranks #5049 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in NBTX as recently as Q4 2024.

Tower Research Capital (TRC) first reported a position in NBTX in Q1 2024 and has held it in 3 quarters since. The position peaked at $22.7K in Q4 2024. 15 funds tracked by Wall St. Rank hold NBTX as of Q1 2026.

  • Tower Research Capital (TRC) held 1 share of Nanobiotix worth $31 as of Q1 2026.
  • Nanobiotix was a new Tower Research Capital (TRC) position in Q1 2026.
  • Nanobiotix made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #5049 holding.
  • Tower Research Capital (TRC) first reported a position in Nanobiotix in Q1 2024 and has held it in 3 quarters since.
  • Tower Research Capital (TRC)'s Nanobiotix position peaked at $22.7K in Q4 2024.
  • 15 funds tracked by Wall St. Rank held Nanobiotix as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.